PRO-C3 as a Biomarker for Liver Fibrosis

被引：0
|
作者：
Kahl, S. [1 ]
机构：
[1] Heinrich Heine Univ, Deutsch Diabet Zentrum, Leibniz Zentrum Diabet Forsch, Inst Klin Diabetol, Hennekamp 65, D-40225 Dusseldorf, Germany
来源：
DIABETOLOGE | 2021年 / 17卷 / 07期
关键词：
D O I：
10.1007/s11428-021-00821-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：758 / 760
页数：3
相关论文
共 50 条
  • [1] PRO-C3 als Biomarker für LeberfibrosePro-C3 as a biomarker for liver fibrosis
    S. Kahl
    Der Diabetologe, 2021, 17 : 758 - 760
  • [2] ANALYSIS OF PRO-C3, A BIOMARKER OF LIVER FIBROSIS, IN CHILDREN WITH NAFLD AND HEALTHY CONTROLS
    Castillo-Leon, Eduardo
    Cioffi, Catherine
    Cleeton, Rebecca L.
    Farris, Alton B., III
    Leeming, Diana Julie
    Shevell, Diane
    Nielsen, Mette J.
    Vos, Miriam B.
    HEPATOLOGY, 2020, 72 : 873A - 873A
  • [3] PRO-C3, liver fibrosis and CKD: The plot thickens
    Lonardo, Amedeo
    LIVER INTERNATIONAL, 2024, 44 (05) : 1126 - 1128
  • [4] Determining a healthy reference range and factors potentially influencing PRO-C3 - A biomarker of liver fibrosis
    Erhardtsen, Elisabeth
    Rasmussen, Daniel G. K.
    Frederiksen, Peder
    Leeming, Diana Julie
    Shevell, Diane
    Gluud, Lise Lotte
    Karsdal, Morten Asser
    Aithal, Guruprasad P.
    Schattenberg, Joern M.
    JHEP REPORTS, 2021, 3 (04)
  • [5] PRO-C3: a new and more precise collagen marker for liver fibrosis in patients with chronic hepatitis C
    Hansen, Janne Fuglsang
    Nielsen, Mette Juul
    Nystrom, Kristina
    Leeming, Diana Julie
    Lagging, Martin
    Norkrans, Gunnar
    Christensen, Peer Brehm
    Karsdal, Morten
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (01) : 83 - 87
  • [6] ASSOCIATIONS OF ENHANCED LIVER FIBROSIS (ELF) AND PRO-C3 WITH STAGE OF FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Felix, Sean
    Lam, Brian P.
    Jeffers, Thomas
    Goodman, Zachary D.
    Stepanova, Maria
    Younossi, Zobair M.
    HEPATOLOGY, 2021, 74 : 803A - 804A
  • [7] ESTABLISHING THE STABILITY, PRECISION, POTENTIAL INFLUENCING FACTORS AND REFERENCE RANGES OF A BIOMARKER OF LIVER FIBROSIS, PRO-C3, IN HEALTHY SUBJECTS, OBESE AND NAFLD PATIENTS
    Daniels, Samuel Joseph
    Erhardtsen, Elisabeth
    Kehlet, Stephanie Nina
    Leeming, Diana Julie
    Shevell, Diane
    Rasmussen, Daniel Guldager Kring
    Gluud, Lise Lotte
    Karsdal, Morten Asser
    Aithal, Guruprasad P.
    Schattenberg, Joern M.
    HEPATOLOGY, 2020, 72 : 911A - 912A
  • [8] Fibrogenesis Marker PRO-C3 Is Higher in Advanced Liver Fibrosis and Improves in Patients Undergoing Bariatric Surgery
    Lassen, Pierre Bel
    Nori, Nicole
    Bedossa, Pierre
    Genser, Laurent
    Aron-Wisnewsky, Judith
    Poitou, Christine
    Surabattula, Rambabu
    Nielsen, Mette Juul
    Karsdal, Morten Asser
    Leeming, Diana Julie
    Schuppan, Detlef
    Clement, Karine
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (04): : E1356 - E1366
  • [9] PRO-C3, a Serological Marker of Fibrosis, During Childhood and Correlations With Fibrosis in Pediatric NAFLD
    Cohen, Catherine C.
    Castillo-Leon, Eduardo
    Farris, Alton B.
    Caltharp, Shelley A.
    Cleeton, Rebecca L.
    Sinclair, Elizabeth M.
    Shevell, Diane E.
    Karsdal, Morten A.
    Nielsen, Mette Juul Fisker
    Leeming, Diana J.
    Vos, Miriam B.
    HEPATOLOGY COMMUNICATIONS, 2021, 5 (11) : 1860 - 1872
  • [10] Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART
    Dold, Leona
    Nielsen, Mette J.
    Praktiknjo, Michael
    Schwarze-Zander, Carolynne
    Boesecke, Christoph
    Schierwagen, Robert
    Mohr, Raphael
    Wasmuth, Jan-Christian
    Jansen, Christian
    Bischoff, Jenny
    Rockstroh, Jurgen Kurt
    Karsdal, Morten A.
    Spengler, Ulrich
    Trebicka, Jonel
    Leeming, Diana J.
    PLOS ONE, 2019, 14 (07):
12345